Cristal Líquido

Research and Development in Release Systems for Gene Therapy

It constitutes the most recent line of research of the group and started with the main researcher of a Thematic Project, which brought together integrated strategies for the Treatment of Tuberculosis, with the main focus on Vaccination and Gene Therapy. The development of this line is consolidating the group in the area of ​​release systems based on liquid crystals, adding knowledge and working techniques. This line opened a new research area, which is the development of delivery systems and carrier molecules for peptide drugs, aligning the group’s research with future trends for the therapies of the most varied pathologies, which at the moment, have numerous limitations of delivery and administration. The delivery systems developed in this line are also being studied for topical application of peptide drugs for the treatment of cutaneous pathologies and topical administration of active ingredients in cosmetics. More recently, the group has been pioneering research on topical and systemic release systems for carrying and releasing siRNA in silencing gene therapy aimed at treating skin diseases such as psoriasis, vitiligo and skin cancer.